Amin Makarem

Stock Analyst at Jefferies

(1.68)
# 3,252
Out of 4,357 analysts
2
Total ratings
50%
Success rate
7.1%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Amin Makarem

UroGen Pharma
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $27.03
Upside: +47.98%
Foghorn Therapeutics
Feb 16, 2026
Maintained: Buy
Price Target: $12
Current: $3.98
Upside: +201.89%